Showing results (1731-1740 of 2,452) with videos related to
Sort By:
Pageof 246
Journal of the National Comprehensive Cancer Network : JNCCN|November 7, 2023
Associations Between Surrogates' Decisional Regret Trajectories and Bereavement OutcomesFur-Hsing Wen, Chia-Hsun Hsieh, Wen-Chi Shen, et al.Journal of the National Comprehensive Cancer Network : JNCCN|October 19, 2023
Machine Learning-Based Early Warning Systems for Acute Care Utilization During Systemic Therapy for CancerRobert C Grant, Jiang Chen He, Ferhana Khan, et al.Journal of the National Comprehensive Cancer Network : JNCCN|July 11, 2023
Ampullary Adenocarcinoma, Version 1.2023, NCCN Clinical Practice Guidelines in OncologyE Gabriela Chiorean, Marco Del Chiaro, Margaret A Tempero, et al.Journal of the National Comprehensive Cancer Network : JNCCN|July 11, 2023
Impact of Asian Race on Prognosis in De Novo Metastatic Prostate CancerXudong Ni, Michael Luu, Weiwei Ma, et al.Journal of the National Comprehensive Cancer Network : JNCCN|August 7, 2023
Compound Kushen Injection Reduces Severe Toxicity and Symptom Burden Associated With Curative Radiotherapy in Patients With Lung CancerJie Liu, Qingxi Yu, Xin Shelley Wang, et al.Journal of the National Comprehensive Cancer Network : JNCCN|August 7, 2023
Changes in Prescribing Patterns in Stage III Colon CancerFang-Shu Ou, Daniel J Walden, Joseph J Larson, et al.Journal of the National Comprehensive Cancer Network : JNCCN|September 6, 2023
NCCN Guidelines® Insights: Breast Cancer Screening and Diagnosis, Version 1.2023Therese B Bevers, Bethany L Niell, Jennifer L Baker, et al.Journal of the National Comprehensive Cancer Network : JNCCN|September 6, 2023
Treatment and Survival Among Patients With Colorectal Cancer in Sub-Saharan Africa: A Multicentric Population-Based Follow-Up StudyLucia Hämmerl, Nikolaus C S Mezger, Tobias P Seraphin, et al.Journal of the National Comprehensive Cancer Network : JNCCN|September 6, 2023
Real-World Impact of Prophylactic Growth Factor Use on Timing of Febrile Neutropenia and Infection After High-Risk ChemotherapyDouglas W Blayney, Nicole M Kuderer, Alice Kate Cummings Joyner, et al.Journal of the National Comprehensive Cancer Network : JNCCN|August 29, 2023
Hormone Receptor-Positive Breast Cancer Sensitive to Pembrolizumab: Evidence of the Pathogenicity of the MLH1 Variant 1835del3Henry G Kaplan, Jeffrey R Whiteaker, Brianna Nelson, et al.Pageof 246